Special Issue "Antimicrobial Peptides of the Innate Immune System as Multifunctional Molecules and Promising Drugs"

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Targeting and Design".

Deadline for manuscript submissions: 20 October 2023 | Viewed by 157

Special Issue Editors

Department of Biochemistry, Saint Petersburg State University, 7/9 Universitetskaya Emb., 199034 St. Petersburg, Russia
Interests: antimicrobial peptides of the innate immune system; antimicrobial activity; antitumor activity; immunomodulatory activity
Department of General Pathology and Pathological Physiology, Institute of Experimental Medicine, Academician Pavlov Street 12, 197022 Saint Petersburg, Russia
Interests: antimicrobial peptides and proteins; complement system
Department of General Pathology and Pathological Physiology, Institute of Experimental Medicine, Academician Pavlov Street 12, 197022 Saint Petersburg, Russia
Interests: innate immune system; antimicrobial peptides and proteins; interaction of AMPs with melanocortin receptors; immunomodulatory activity

Special Issue Information

Dear Colleagues,

Antimicrobial peptides are effector molecules of the innate immune system in humans and animals. They provide rapid anti-infective protection against bacteria, fungi, some viruses and pathogenic protozoa. AMPs have a variety of primary and secondary structures and therefore different physico-chemical and biological features. In addition to their direct antimicrobial activity, AMPs exert multiple modulatory effects on host cells. Due to this versatility, AMPs have received an alternative name: host defense peptides (HDPs). These peptides demonstrate a broad spectrum of biological activities, acting as immune modulators as well as antitumor, anti-inflammatory, stress-limiting, neuroprotective, chemotactic and wound-healing substances and are often used as templates in creating new pharmaceutics. This Special Issue is aimed at presenting new data on various types of AMP activity, their mechanisms of action on diverse targets (bacteria, fungi, viruses, normal and tumor host cells), interaction with cell membranes, specific receptors, complement system, etc., and the prospects of their practical application as novel antimicrobials against multidrug-resistant pathogens or malignant cells, as well as immunomodulatory, anti-inflammatory, wound-healing, complement modulating pharmaceutics. Original research articles or reviews are welcome.

Research areas may include (but are not limited to) the following:

  • AMPs as templates for creation novel antibiotics for combating drug-resistant microorganisms;
  • Immunomodulatory activity of AMPs;
  • AMPs as promising pharmaceutics in combination therapy of oncological or infectious diseases;
  • Interaction of AMPs with host cell receptors;
  • Anti-inflammatory action of AMPs;
  • Prospects of application of AMPs as complement inhibitors;
  • Synergy of AMPs with antimicrobial, antitumor, immunomodulatory medications;
  • AMPs as wound healing tools.

We look forward to receiving your contribution.

Prof. Dr. Olga V. Shamova
Dr. Mikhail N. Berlov
Dr. Galina M. Aleshina
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • antimicrobial peptides
  • antimicrobial activity
  • immunomodulatory activity
  • antitumor activity
  • modulators of the complement system
  • corticostatic activity
  • wound-healing activity
  • combined antibiotic action

Published Papers

This special issue is now open for submission.
Back to TopTop